Montelukast attenuates the airway response to hypertonic saline in moderate-to-severe COPD Source: Eur Respir J 2003 Dec 01;22(6):926-930 Year: 2003
Nebulized saline treatment in patients with concomitant asthma and bronchiectasis Source: Virtual Congress 2021 – Bronchiectasis and pleural infection Year: 2021
Increased levels of histamine in sputum after inhalation of hypertonic saline in patients with COPD Source: Eur Respir J 2001; 18: Suppl. 33, 24s Year: 2001
Effects of regular formoterol treatment on airway hyperresponsiveness in patients with mild to moderate asthma Source: Eur Respir J 2003; 22: Suppl. 45, 285s Year: 2003
Refractoriness following hypertonic saline challenge attenuates nocturnal asthma Source: Annual Congress 2007 - Current issues in airway physiology, pharmacology and monitoring Year: 2007
Therapeutic saline inhalation: effects on lung function and dyspnoea in patients with chronic obstructive airway diseases Source: Eur Respir J 2001; 18: Suppl. 33, 484s Year: 2001
Hypertonic histamine challenge induced cough in assessing the treatment response to inhaled corticosteroid in asthma Source: Annual Congress 2008 - Cough and airway hyperresponsiveness Year: 2008
The effects of capsaicin on airway inflammation in asthma patients Source: Eur Respir J 2004; 24: Suppl. 48, 586s Year: 2004
Effects of formoterol-budesonide combination on residual eosinophilic inflammation in distal airway of patients with well-controlled moderate asthma Source: Annual Congress 2011 - Asthma management and response Year: 2011
Protective effect of salbutamol on peripheral airway constriction induced by sputum induction in asthma patients Source: International Congress 2017 – Biomarker-based asthma control Year: 2017
Inhaled corticosteroid improved the perception of dyspnea during methacholine induced bronchoconstriction and changed the hypoxic ventilatory response in patients with asthma Source: Eur Respir J 2002; 20: Suppl. 38, 49s Year: 2002
The acute effect of loaded inspirations upon airway resistance in mild to moderate asthmatics Source: Annual Congress 2007 - Advances in respiratory mechanics Year: 2007
Tiotropium + olodaterol in patients with moderate to severe COPD with chronic bronchitis and/or emphysema Source: International Congress 2016 – Pharmacological treatment of COPD: focus on LABA/LAMA combinations Year: 2016
Salmeterol/fluticasone therapy improves FEV1 in mild and moderate more than in severe COPD patients Source: Eur Respir J 2004; 24: Suppl. 48, 342s Year: 2004
Short-term treatment with sistemic corticosteroids blunted neutrophilic airway response to ozone in mild asthmatics Source: Eur Respir J 2002; 20: Suppl. 38, 569s Year: 2002
R411 treatment reduces asthma exacerbations and attenuates FEV1 fall following steroid withdrawal in moderate asthma Source: Eur Respir J 2005; 26: Suppl. 49, 252s Year: 2005
Inhaled corticosteroids in patients with mild to moderate COPD with and without airway hyperresponsiveness to mannitol: A randomized placebo controlled trial Source: Annual Congress 2011 - Biomarkers and exacerbations of asthma and COPD Year: 2011
Inhaled racemic salbutamol may cause enhanced bronchial response to cold air in mild asthmatics Source: Eur Respir J 2001; 18: Suppl. 33, 105s Year: 2001
Effect of an inhaled alpha4-antagonist on the allergen-induced late asthmatic response in patients with mild asthma Source: Eur Respir J 2005; 26: Suppl. 49, 135s Year: 2005
Hypertonic saline cough provocation test with salbutamol pre-treatment: evidence for sensorineural dysfunction in asthma Source: Annual Congress 2008 - Pulmonary vascular disease and other pulmonary conditions: miscellaneous Year: 2008